DEEP RESERVOIR TEMPERATURES OF LOW-ENTHALPY GEOTHERMAL SYSTEMS IN TUNISIA: NEW CONSTRAINTS FROM CHEMISTRY OF THERMAL WATERS

Tunisia is characterized by hot and warm groundwaters (temperature up to 75 °C) which represent the surface manifestation of geothermal systems hosted in carbonate-evaporite rock sequences. The T-conditions of Tunisia deep thermal reservoirs are here evaluated for the first time at the regional scale. The results here shown clearly highlight the limitations inherent in the application of common geothermometric methods in the estimation of equilibrium temperatures in sedimentary environments. The modeling approach proposed by Chiodini et alii (1995), which makes use of the ratios between dissolved HCO3, SO4 and F, provides the most reliable results, and allows us to derive equilibrium temperatures up to 200 °C for the Tunisian thermal reservoirs. Very high equilibrium pCO2 (100 bar) values are also estimated, likely indicative of the confined aquifer conditions

Micrometastasis Detection Guidance by Whole-Slide Image Texture Analysis in Colorectal Lymph Nodes

Introduction/ Background Cancer is a disease that affects millions worldwide and accurate determination of whether lymph nodes (LNs) near the primary tumor contain metastatic foci is of critical importance for proper patient management. Histopathological evaluation is the only accepted method to make that determination. However, the current standard of care only examines a single central histological section per LN and yields an unacceptable false-negative rate. Aims To help pathologists in their examination we propose a method that extracts textural features from histopathological LN whole slide images (WSI) and then applies support vector machines (SVMs) to automatically identify regions suspicious for metastatic foci. Methods The database consisted of WSI from 44 LNs. Sections were stained with hematoxylin-eosin and examined at 20x (0.45μm resolution). Twenty-eight of the LNs were identified by an expert pathologist as positive for cancer (P), and the remaining sixteen were negative (N). This database was divided into two groups. Group 1 (15P and 5N) was used for training and Group 2 (13P and 11N) was used for testing the classification technique. For all analysis each WSI was divided into non-overlapping 1000 x 1000 pixel sub-images that will be referred to as high-power fields (HPFs). For each LN in Group 1, at least one WSI was annotated by a pathologist to identify rectangular, HPF-scale regions as locally cancerous or locally non-cancerous. From these annotated slides, 924 HPFs (462 P and 462 N) were obtained. For each of these HPFs, statistical features based on gray-level co-occurrence matrices [1] and Law’s texture energy measures [2, 3] were extracted from 9 derived images [4]. The extracted features were submitted to a sequential forward selection (SFS) method [5] to select few non-redundant features providing best class separation (cancerous vs. non-cancerous region). Combinations of the selected features were tested on the 924 HPFs using k-fold cross-validation to find those that produced the best results and consequently to train our SVM-based classifier. In Group 2, WSI were not annotated for cancerous and non-cancerous zones on a HPF scale. Each LN, however, had been labeled by a pathologist as positive or negative for cancer. For each WSI, each section was divided into contiguous HPFs, and those which mainly contain fatty tissue, background, and tears were automatically excluded. Each selected HPFs was classified as cancerous or non-cancerous using the previously trained classifier to obtain the total number of cancer-classified per LN. A receiver operating characteristics (ROC) curve was traced by changing the discriminator threshold (T) used to label the LN as P for cancer as a function of the total number of cancer-classified HPFs. Results During training, 5 Laws features were selected by SFS. Highly satisfactory k-fold cross-validation with a F-score of 0.996 ± 0.005 was obtained using only 2 statistical features computed at different scales. The ROC curve obtained by applying the SVM-classifier to the test set is shown in the next figure. Two valuable operating points can be identified which both guaranteed no false-negative. At T=11 we got 2 false-positives and an optimal F-score of 0.917, and with a more conservative approach, T=1, we got 7 false-positives and a F-score of 0.759. The top-left part of the slide displayed in next figure would have been proposed to the pathologist as the most suspicious region of the cancerous LN

Forgetting of long-term memory requires activation of NMDA receptors, L-type voltage-dependent Ca(2+) channels, and calcineurin

In the past decades, the cellular and molecular mechanisms underlying memory consolidation, reconsolidation, and extinction have been well characterized. However, the neurobiological underpinnings of forgetting processes remain to be elucidated. Here we used behavioral, pharmacological and electrophysiological approaches to explore mechanisms controlling forgetting. We found that post-acquisition chronic inhibition of the N-methyl-D-aspartate receptor (NMDAR), L-type voltage-dependent Ca2+ channel (LVDCC), and protein phosphatase calcineurin (CaN), maintains long-term object location memory that otherwise would have been forgotten. We further show that NMDAR activation is necessary to induce forgetting of object recognition memory. Studying the role of NMDAR activation in the decay of the early phase of long-term potentiation (E-LTP) in the hippocampus, we found that ifenprodil infused 30min after LTP induction in vivo blocks the decay of CA1-evoked postsynaptic plasticity, suggesting that GluN2B-containing NMDARs activation are critical to promote LTP decay. Taken together, these findings indicate that a well-regulated forgetting process, initiated by Ca2+ influx through LVDCCs and GluN2B-NMDARs followed by CaN activation, controls the maintenance of hippocampal LTP and long-term memories over time

Dopaminergic D1 receptor signalling is necessary, but not sufficient for cued fear memory destabilisation

Rationale. Pharmacological targeting of memory reconsolidation is a promising therapeutic strategy for the treatment of fear memory-related disorders. However, the success of reconsolidation-based approaches depends upon the effective destabilisation of the fear memory by memory reactivation. Objectives. Here, we aimed to determine the functional involvement of dopamine D1 receptors in cued fear memory destabilisation, using systemic drug administration. Results. We observed that direct D1 receptor agonism was not sufficient to stimulate tone fear memory destabilisation to facilitate reconsolidation disruption by the glucocorticoid receptor antagonist mifepristone. Instead, administration of the nootropic nefiracetam did facilitate mifepristone-induced amnesia, in a manner that was dependent upon dopamine D1 receptor activation, although. Finally, while the combined treatment with nefiracetam and mifepristone did not confer fear-reducing effects under conditions of extinction learning, there was some evidence that mifepristone reduces fear expression irrespective of memory reactivation parameters. Conclusions. The use of combination pharmacological treatment to stimulate memory destabilisation and impair reconsolidation has potential therapeutic benefits, without risking a maladaptive increase of fear

Disrupting astrocyte-neuron lactate transfer persistently reduces conditioned responses to cocaine.

A central problem in the treatment of drug addiction is the high risk of relapse often precipitated by drug-associated cues. The transfer of glycogen-derived lactate from astrocytes to neurons is required for long-term memory. Whereas blockade of drug memory reconsolidation represents a potential therapeutic strategy, the role of astrocyte-neuron lactate transport in long-term conditioning has received little attention. By infusing an inhibitor of glycogen phosphorylase into the basolateral amygdala of rats, we report that disruption of astrocyte-derived lactate not only transiently impaired the acquisition of a cocaine-induced conditioned place preference but also persistently disrupted an established conditioning. The drug memory was rescued by L-Lactate co-administration through a mechanism requiring the synaptic plasticity-related transcription factor Zif268 and extracellular signal-regulated kinase (ERK) signalling pathway but not the brain-derived neurotrophic factor (Bdnf). The long-term amnesia induced by glycogenolysis inhibition and the concomitant decreased expression of phospho-ERK were both restored with L-Lactate co-administration. These findings reveal a critical role for astrocyte-derived lactate in positive memory formation and highlight a novel amygdala-dependent reconsolidation process, whose disruption may offer a novel therapeutic target to reduce the long-lasting conditioned responses to cocaine

Repeated Labilization-Reconsolidation Processes Strengthen Declarative Memory in Humans

The idea that memories are immutable after consolidation has been challenged. Several reports have shown that after the presentation of a specific reminder, reactivated old memories become labile and again susceptible to amnesic agents. Such vulnerability diminishes with the progress of time and implies a re-stabilization phase, usually referred to as reconsolidation. To date, the main findings describe the mechanisms associated with the labilization-reconsolidation process, but little is known about its functionality from a biological standpoint. Indeed, two functions have been proposed. One suggests that destabilization of the original memory after the reminder allows the integration of new information into the background of the original memory (memory updating), and the other suggests that the labilization-reconsolidation process strengthens the original memory (memory strengthening). We have previously reported the reconsolidation of human declarative memories, demonstrating memory updating in the framework of reconsolidation. Here we deal with the strengthening function attributed to the reconsolidation process. We triggered labilization-reconsolidation processes successively by repeated presentations of the proper reminder. Participants learned an association between five cue-syllables and their respective response-syllables. Twenty-four hours later, the paired-associate verbal memory was labilized by exposing the subjects to one, two or four reminders. The List-memory was evaluated on Day 3 showing that the memory was improved when at least a second reminder was presented in the time window of the first labilization-reconsolidation process prompted by the earlier reminder. However, the improvement effect was revealed on Day 3, only when at least two reminders were presented on Day2 and not as a consequence of only retrieval. Therefore, we propose central concepts for the reconsolidation process, emphasizing its biological role and the parametrical constrains for this function to be operative

The CB1 receptor antagonist AM251 impairs reconsolidation of pavlovian fear memory in the rat basolateral amygdala

We have investigated the requirement for signaling at CB1 receptors in the reconsolidation of a previously consolidated auditory fear memory, by infusing the CB1 receptor antagonist AM251, or the FAAH inhibitor URB597, directly into the basolateral amygdala (BLA) in conjunction with memory reactivation. AM251 disrupted memory restabilization, but only when administered after reactivation. URB597 produced a small, transient enhancement of memory restabilization when administered after reactivation. The amnestic effect of AM251 was rescued by coadministration of the GABAA receptor antagonist bicuculline at reactivation, indicating that the disruption of reconsolidation was mediated by altered GABAergic transmission in the BLA. These data show that the endocannabinoid system in the BLA is an important modulator of fear memory reconsolidation and that its effects on memory are mediated by an interaction with the GABAergic system. Thus, targeting the endocannabinoid system may have therapeutic potential to reduce the impact of maladaptive memories in neuropsychiatric disorders such as posttraumatic stress disorder.This work was conducted within the Behavioural and Clinical Neuroscience Institute, a joint initiative funded by the Wellcome Trust and the UK Medical Research Council, in the Department of Psychology at the University of Cambridge. This work was funded by a UK Medical Research Council programme grant (no. G1002231) awarded to BJE and ALM. PR was supported by a Department of Physiology and Pharmacology Fellowship at the Sapienza University of Rome, and an Italian Society of Pharmacology Fellowship. ALM is the Ferreras-Willetts Fellow in Neuroscience at Downing College, Cambridge. The manuscript was partly prepared while ALM was an Erskine Visiting Cambridge Fellow at the University of Canterbury, Christchurch, New Zealand